FDA-approved drugs in each class GLP-1 receptor agonist medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound also a GIP agonist), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
and a lower risk of developing, as well as improved management of, type 2 diabetes
NEURODEGENERATIVE DISEASES: ALZHEIMERS AND PARKINSONS DISEASES An analysis of the mechanisms of action of GLP-1 and GLP-1RAs indicates that these compounds, by activating GLP-1R, modulate the molecular and cellular changes, and influence the shared processes that determine the phenomenology of neurodegenerative diseases (NDD) and a number of other brain diseases [36]
Cui Y, Chen Y, Gan N, Li M, Liao W, Zhou Y
Eli Lilly, which sells tirzepatide under the brand names Mounjaro and Zepbound, sent a flurry of cease-and-desist letters to hundreds of companies selling compounded versions
Whether you are working with your first vial or your fifth, the math here is precise, the instructions are clear, and every number has been double-checked against established peptide dosing protocols
